DA
BHVN icon

DCF Advisers’s Biohaven BHVN Stock Holding History

DCF Advisers’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,500
Closed -$52.1K – 98
2024
Q2 		$52.1K Buy
+1,500
New +$59.3K 0.03% 89

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCF Advisers's BHVN Position: Q1 2026 in Review

DCF Advisers reduced its Biohaven (BHVN) stake by 18% in Q1 2026, selling an estimated $306K and leaving 123,500 shares worth $1.04M. The position accounts for 0.28% of the portfolio, ranked #57.

DCF Advisers first reported a position in BHVN in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.57M in Q3 2025. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • DCF Advisers held 123,500 shares of Biohaven worth $1.04M as of Q1 2026.
  • DCF Advisers sold 28,000 Biohaven shares in Q1 2026, an estimated $306K.
  • Biohaven made up 0.28% of DCF Advisers's portfolio in Q1 2026, its #57 holding.
  • DCF Advisers first reported a position in Biohaven in Q2 2024 and has held it in 8 quarters since.
  • DCF Advisers's Biohaven position peaked at $2.57M in Q3 2025.
  • 275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on DCF Advisers's 13F filing for Q1 2026, filed 11 May 2026.